Planned Clinical Trial of Allogeneic Stem Cell Therapy Remestemcel-L in Patients with COVID-19

Mount Sinai Health System announced that they will be using the allogeneic stem cell therapy remestemcel-L in patients with COVID-19, and have already tested the therapy in 10 patients.

Source: CancerNetwork - April 20, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news